| March 25, 2021
Related Articles
View allDevyser Diagnostics AB publishes quarterly report for the period April to June 2024
“Devyser continued to report high sales growth in the second quarter. Organic growth compared with...
Read More
Devyser wins tender in Italy for its cystic fibrosis NGS test worth up to 5.9 million SEK
Read More
Devyser wins tender in Sweden for Thalassemia NGS testing worth up to 8.4 million SEK
Read More